1. Kyritsis AP, Zhang B, Zhang W, Xiao M, Takeshima H, Bondy ML, et al. Mutations of the p16 gene in gliomas. Oncogene. 1996;12:63–7.
2. Levin VA, Giglio P, Kyritsis AP. The management of gliomas, medulloblastomas, CNS germ cell tumors and carcinomas metastatic to the CNS. In: Cavalli F, Hansen H, Kaye S, editors. Textbook of medical oncology. 3rd ed. New York: Taylor & Francis; 2004. p. 313–33.
3. Alexiou GA, Moschovi M, Stefanaki K, Panagopoulos D, Tsotra M, Siozos G, et al. Supratentorial ependymomas in children: analysis of nine cases. J Pediatr Neurosci. 2013;8:15–8.
4. Levin VA. Personalized medicine in neuro-oncology. CNS Oncol. 2016;5:55–8.
5. Alexiou GA, Goussia A, Kyritsis AP, Tsiouris S, Ntoulia A, Malamou-Mitsi V, et al. Influence of glioma’s multidrug resistance phenotype on (99m) Tc-tetrofosmin uptake. Mol Imaging Biol. 2011;13:348–51.